and

ZEISS launches Collaborative Care application to strengthen continuity of care; new solution offers on-premises and cloud-based options

Built on the ZEISS Health Data Platform, ZEISS Collaborative Care offers eye care professionals a flexible way to collaborate –…

1 month ago

Bitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 4.423 Million Tokens, and Total Crypto and Total Cash Holdings of $9.6 Billion

Bitmine has 3,040,483 staked ETH, representing $6.0 billion at $1,958 per ETH; MAVAN staking solution on track to launch Q1…

1 month ago

Versos AI Launches the First End-to-End Solution for Preparing and Licensing Video Training Data for AI

SAINT JOHN, New Brunswick, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Versos AI Inc. today announced the launch of the Video…

1 month ago

GovSignals Achieves DoW IL5 Authorization with Second Front Systems, Bringing Secure Acquisition AI to Defense and Federal Missions

NEW YORK, Feb. 23, 2026 (GLOBE NEWSWIRE) -- GovSignals, the acquisition AI platform for government contracting, and Second Front Systems…

1 month ago

AI-focused DreamzTech Solutions named to TIME’s Fastest-Growing Companies 2026 list and Forbes DGEMS 2025 Select 200

KOLKATA, India, Feb. 23, 2026 /PRNewswire/ -- DreamzTech Solutions announced that it has been named to TIME & Statista's India's…

1 month ago

Thermobalancing therapy emerges as drug-free option for BPH, chronic prostatitis, back pain and kidney stones

Oxford, UK, Feb. 21, 2026 (GLOBE NEWSWIRE) -- Therapeutic Dr Allen’s Devices are designed to treat different chronic health conditions,…

2 months ago

U.S. Food and Drug Administration (FDA) Accepts Tevas New Drug Application (NDA) for Olanzapine Extended-Release Injectable Suspension (TEV-‘749) for the Once-Monthly Treatment of Schizophrenia in Adults

Olanzapine long-acting injectable (LAI) suspension (TEV-'749) has the potential to offer the efficacy of olanzapine in a once-monthly, subcutaneous formulation1If…

2 months ago

VERSES Announces Filing of Quarterly Report on Form 10-Q for the Three and Nine-Months Ended December 31, 2025

February 20, 2026 19:11 ET  | Source: VERSES AI Inc. VANCOUVER, British Columbia, Feb. 20, 2026 (GLOBE NEWSWIRE) -- VERSES…

2 months ago

Bel Fuse Inc. Announces Regular Quarterly Cash Dividend on its Class A and Class B Shares

February 20, 2026 16:49 ET  | Source: Bel Fuse Inc. WEST ORANGE, N.J., Feb. 20, 2026 (GLOBE NEWSWIRE) -- BEL…

2 months ago

Amicus Therapeutics Announces Full-Year 2025 Financial Results and Corporate Updates

2025 Total Revenue of $634M, up 17% Year-over-Year at CER Cash Position of $294M, a $44M Increase in 2025 Proposed…

2 months ago